A team of international researchers led by Prof Martin Hegner, Investigator in CRANN and Trinity’s School of Physics developed an automated diagnostic platform that indicates bleeding – and thrombotic risks in one drop of blood within seconds (Nanoscale, “Towards personalised rapid label free miRNA detection for cancer and liver injury diagnostics in cell lysates and blood based samples”).
They exploit micro-resonators for real-time measurements of the evolving blood plasma clot strength. Along with the clinically measured clotting time, other parameters, from specific factor deficiency to global coagulation parameters to assess fibrinolysis, can be extracted.
These technical developments now open up the possibility to introduce a miniaturized global haemostasis assay with capability to fine-tune anti-coagulation therapies.
In collaboration with the multinational Hoffman-la-Roche they report a novel strategy for quick, reliable and quantitative diagnostics of expression patterns of non-coding short RNA in blood plasma or cell cultures. They directly detect label-free specific miRNA biomarkers relevant to cancer and adverse drug effects in blood-based samples (right image).
Image Credit: CRANN
News This Week
Gold Nanoparticles Act as Tumor-seeking Missiles
A small clinical trial using gold nanoparticles that act as tumor-seeking missiles on a mission to remove prostate cancer has begun at The University of Texas Health Science Center at Houston (UTHealth). It is [...]
Artificial synapses made from nanowires
Scientists from Jülich together with colleagues from Aachen and Turin have produced a memristive element made from nanowires that functions in much the same way as a biological nerve cell. The component is able [...]
Interactive size control of catalyst nanoparticles
How many nanometers should catalyst nanoparticles be to optimize the course of the reaction? Researchers usually look for the answer through laborious, repetitive tests. At the Institute of Physical Chemistry of the Polish Academy [...]
Nanotechnology, Nanomedicine, and AI: What is Global Health Care Equivalency (GHCE)
What is Global Health Care Equivalency (GHCE)? Looking ahead over the next 10-30 years, with the rapid emergence of, and synergies between, the disciplines of nanotechnology, nanomedicine, and AI, we can envisage a future [...]
Prostate cancer patients could avoid chemotherapy with new blood test
A new development in the testing of one of Australia's biggest cancer killers, prostate cancer, could help avoid unncessary chemotherapy and improve the treatment of patients. Sydney researchers have developed a blood test which [...]
Updated – NanoApps Medical Inc. Near-Term Projects
NanoApps Medical is investigating the possibility that superparamagnetic nanoparticles (SPIONs) (Figure 1) and other classes of nanoparticles (e.g., gold coated nanoshells) (Figure 2) might have the capacity to target cancerous tumors, metastasizing cancer cells, [...]
Nonstop tranport of cargo in nanomachines
Moving around, sensing the extracellular environment, and signaling to other cells are important for a cell to function properly. Responsible for those tasks are cilia, antenna-like structures protruding from most vertebrate cells. Whenever cilia [...]
A major step toward non-viral ocular gene therapy using laser and nanotechnology
In January 2009, the life of engineer Michel Meunier, a professor at Polytechnique Montréal, changed dramatically. Like others, he had observed that the extremely short pulse of a femtosecond laser (0.000000000000001 second) could make [...]
Leave A Comment